ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 817

$891K Total Retail Price of All Prescriptions

Rank: 30 out of 817

638 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 638 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 638 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 16,566 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $89 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 807 794 1 10
SIMVASTATIN 726 667 2 1
LEVOTHYROXINE SODIUM 664 640 3 2
FUROSEMIDE 572 563 4 8
OMEPRAZOLE 512 499 5 4
AMLODIPINE BESYLATE 467 459 6 6
POTASSIUM CHLORIDE 460 455 7 18
METOPROLOL TARTRATE 423 406 8 5
LISINOPRIL 402 388 9 3
CITALOPRAM HBR 365 345 10 16
DONEPEZIL HCL 356 353 11 20
NAMENDA 316 309 12 33
TRAZODONE HCL 307 264 13 41
ATENOLOL 301 298 14 14
DIOVAN 301 289 14 28
QUETIAPINE FUMARATE 263 252 16 62
MIRTAZAPINE 258 258 17 40
HYDROCODONE-ACETAMINOPHEN 237 182 S3 18 7
METFORMIN HCL 231 202 19 13
TRAMADOL HCL 222 216 20 23
ATORVASTATIN CALCIUM 216 198 21 9
GABAPENTIN 214 185 22 12
SERTRALINE HCL 207 201 23 24
EXELON 195 194 24 123
POLYETHYLENE GLYCOL 3350 163 161 25 86
TAMSULOSIN HCL 157 146 26 11
RISPERIDONE 145 140 27 51
AZITHROMYCIN 139 134 28 53
KLOR-CON M20 137 136 29 61
QUINAPRIL HCL 134 134 30 72
ALLOPURINOL 131 131 31 50
ROPINIROLE HCL 121 114 32 160
LANTUS 115 106 33 64
ALENDRONATE SODIUM 113 112 34 31
DIGOXIN 105 105 35 37
FAMOTIDINE 104 98 36 71
PREDNISONE 102 98 37 17
BUSPIRONE HCL 101 101 38 178
CARBIDOPA-LEVODOPA 99 99 39 52
CIPROFLOXACIN HCL 95 94 40 39
FENTANYL 91 91 S2 41 58
TRIAMCINOLONE ACETONIDE 91 88 41 97
BUMETANIDE 89 89 43 146
KETOCONAZOLE 89 53 43 141
LOPERAMIDE 88 87 45 323
PRAVASTATIN SODIUM 88 75 45 19
HYDROCHLOROTHIAZIDE 87 81 47 15
GLIPIZIDE 84 84 48 84
RANITIDINE HCL 82 80 49 42
METOPROLOL SUCCINATE 82 76 49 26
SEROQUEL 82 82 49 181
CEPHALEXIN 80 80 52 102
CARVEDILOL 80 71 52 21
CLOPIDOGREL 78 67 54 27
SPIRIVA 77 77 55 35
PANTOPRAZOLE SODIUM 77 77 55 22
ESCITALOPRAM OXALATE 75 75 57 74
CELEBREX 74 71 58 65
ZOLPIDEM TARTRATE 71 63 59 30
PAROXETINE HCL 70 69 60 94
JANUVIA 66 60 61 66
AVELOX 65 64 62 417
IBUPROFEN 64 52 63 82
DILTIAZEM 24HR CD 59 59 64 120
GLIMEPIRIDE 58 55 65 88
ADVAIR DISKUS 55 50 66 32
LOSARTAN POTASSIUM 55 55 66 29
IPRATROPIUM-ALBUTEROL 54 54 68 185
CLOTRIMAZOLE 54 54 68 495
AMLODIPINE BESYLATE-BENAZEPRIL 52 28 70 83
PROCHLORPERAZINE MALEATE 51 48 71 308
DIOVAN HCT 50 49 72 95
ZETIA 50 47 72 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.